ACT Stock Overview
AlzChem Group AG, together with its subsidiaries, develops, produces, and trades chemical products in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
AlzChem Group AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €46.70 |
| 52 Week High | €47.00 |
| 52 Week Low | €17.55 |
| Beta | 1.1 |
| 1 Month Change | 40.24% |
| 3 Month Change | 81.71% |
| 1 Year Change | 145.14% |
| 3 Year Change | 82.42% |
| 5 Year Change | 103.04% |
| Change since IPO | 73.67% |
Recent News & Updates
Is AlzChem Group (ETR:ACT) A Risky Investment?
Apr 11
AlzChem Group's (ETR:ACT) Dividend Will Be Increased To €1.20
Mar 29Recent updates
Is AlzChem Group (ETR:ACT) A Risky Investment?
Apr 11AlzChem Group's (ETR:ACT) Dividend Will Be Increased To €1.20
Mar 29The Market Lifts AlzChem Group AG (ETR:ACT) Shares 26% But It Can Do More
Mar 07Why AlzChem Group AG (ETR:ACT) Could Be Worth Watching
Nov 01Is There An Opportunity With AlzChem Group AG's (ETR:ACT) 42% Undervaluation?
Oct 12AlzChem Group (ETR:ACT) Is Increasing Its Dividend To €1.05
May 06AlzChem Group AG's (ETR:ACT) CEO Compensation Is Looking A Bit Stretched At The Moment
May 05AlzChem Group (ETR:ACT) Will Pay A Larger Dividend Than Last Year At €1.05
Apr 05AlzChem Group (ETR:ACT) Is Increasing Its Dividend To €1.05
Mar 04AlzChem Group (ETR:ACT) Is Paying Out A Larger Dividend Than Last Year
Apr 24AlzChem Group's (ETR:ACT) Dividend Will Be Increased To €1.00
Mar 29AlzChem Group (ETR:ACT) Has Announced That It Will Be Increasing Its Dividend To €1.00
Feb 27AlzChem Group (ETR:ACT) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Nov 23Are Investors Undervaluing AlzChem Group AG (ETR:ACT) By 46%?
Jun 10At €24.50, Is AlzChem Group AG (ETR:ACT) Worth Looking At Closely?
Apr 07AlzChem Group AG (ETR:ACT) Is Yielding 3.0% - But Is It A Buy?
Mar 23AlzChem Group AG's (ETR:ACT) Intrinsic Value Is Potentially 32% Above Its Share Price
Mar 10Is AlzChem Group AG's (ETR:ACT) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Feb 24Our Take On The Returns On Capital At AlzChem Group (ETR:ACT)
Feb 11
Update: AlzChem Group (ETR:ACT) Stock Gained 13% In The Last Year
Aug 07Is Now An Opportune Moment To Examine AlzChem Group AG (ETR:ACT)?
Jul 20Does This Valuation Of AlzChem Group AG (ETR:ACT) Imply Investors Are Overpaying?
Jul 03Shareholder Returns
| ACT | DE Chemicals | DE Market | |
|---|---|---|---|
| 7D | 6.6% | 0.5% | 1.8% |
| 1Y | 145.1% | 0.2% | 2.2% |
Return vs Industry: ACT exceeded the German Chemicals industry which returned -1.2% over the past year.
Return vs Market: ACT exceeded the German Market which returned -0.3% over the past year.
Price Volatility
| ACT volatility | |
|---|---|
| ACT Average Weekly Movement | 5.2% |
| Chemicals Industry Average Movement | 4.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.1% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: ACT's share price has been volatile over the past 3 months.
Volatility Over Time: ACT's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1908 | 1,607 | Andreas Niedermaier | www.alzchem.com |
AlzChem Group AG, together with its subsidiaries, develops, produces, and trades chemical products in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The company offers dietary supplements under the Creapure and Alipure brands; preparation of guanidinoacetic acid as a nutritional feed additives under the Creamino brand; creatine dietary supplements under the LIVADUR brand; products for pharmaceuticals under the Bioselect brand; curing agents, including accelerators for use in adhesives, powder coatings, printed circuit boards, and composites under the DYHARD name; and silicon nitride for ceramics, and electronics and solar applications under the SILZOT brand.
AlzChem Group AG Fundamentals Summary
| ACT fundamental statistics | |
|---|---|
| Market cap | €475.23m |
| Earnings (TTM) | €34.62m |
| Revenue (TTM) | €545.79m |
13.7x
P/E Ratio0.9x
P/S RatioIs ACT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ACT income statement (TTM) | |
|---|---|
| Revenue | €545.79m |
| Cost of Revenue | €241.72m |
| Gross Profit | €304.07m |
| Other Expenses | €269.45m |
| Earnings | €34.62m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 29, 2024
| Earnings per share (EPS) | 3.40 |
| Gross Margin | 55.71% |
| Net Profit Margin | 6.34% |
| Debt/Equity Ratio | 35.2% |
How did ACT perform over the long term?
See historical performance and comparisonDividends
2.6%
Current Dividend Yield35%
Payout RatioDoes ACT pay a reliable dividends?
See ACT dividend history and benchmarks| AlzChem Group dividend dates | |
|---|---|
| Ex Dividend Date | May 08 2024 |
| Dividend Pay Date | May 10 2024 |
| Days until Ex dividend | 14 days |
| Days until Dividend pay date | 16 days |
Does ACT pay a reliable dividends?
See ACT dividend history and benchmarks